Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 5
2000 3
2001 1
2002 5
2003 1
2004 3
2005 4
2006 3
2007 1
2008 4
2009 4
2010 5
2011 10
2012 7
2013 9
2014 12
2015 7
2016 14
2017 14
2018 18
2019 14
2020 8
2021 19
2022 11
2023 10
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Severe Hypothyroidism-A Less Known Mimicker of Amyloid Cardiomyopathy?
Fazzini L, Castrichini M, Bois MC, Natt N, Chang IC, Grogan M, Pereira NL, AbouEzzeddine OF. Fazzini L, et al. Among authors: pereira nl. Mayo Clin Proc. 2024 Dec;99(12):2008-2011. doi: 10.1016/j.mayocp.2024.09.014. Mayo Clin Proc. 2024. PMID: 39631992 No abstract available.
Exercise-induced Reduction in Left Ventricular Ejection Fraction in the Absence of Coronary Artery Disease: Clinical Characteristics and Outcomes.
Fazzini L, Hubers SA, Cao JJ, Scott CG, McCully RB, Castrichini M, Figueiral M, Mohananey A, Wang L, Gulati R, Montisci R, Pellikka PA, Pereira NL. Fazzini L, et al. Among authors: pereira nl. J Am Soc Echocardiogr. 2024 Nov 27:S0894-7317(24)00588-1. doi: 10.1016/j.echo.2024.11.008. Online ahead of print. J Am Soc Echocardiogr. 2024. PMID: 39613116
N-cadherin antagonism is bronchoprotective in severe asthma models.
Pereira NL, Schaible N, Desai A, Chan EC, Ablooglu AJ, Capuano J, Lin E, An Z, Gebski E, Jester W, Ganesan S, Balenga N, Koziol-White C, Panettieri RA Jr, Choudhury S, Krishnan R, Druey KM. Pereira NL, et al. Sci Adv. 2024 Nov 29;10(48):eadp8872. doi: 10.1126/sciadv.adp8872. Epub 2024 Nov 29. Sci Adv. 2024. PMID: 39612338 Free PMC article.
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.
Angiolillo DJ, Galli M, Alexopoulos D, Aradi D, Bhatt DL, Bonello L, Capodanno D, Cavallari LH, Collet JP, Cuisset T, Ferreiro JL, Franchi F, Geisler T, Gibson CM, Gorog DA, Gurbel PA, Jeong YH, Marcucci R, Siller-Matula JM, Mehran R, Neumann FJ, Pereira NL, Rizas KD, Rollini F, So DYF, Stone GW, Storey RF, Tantry US, Berg JT, Trenk D, Valgimigli M, Waksman R, Sibbing D. Angiolillo DJ, et al. Among authors: pereira nl. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2639-2663. doi: 10.1016/j.jcin.2024.08.027. JACC Cardiovasc Interv. 2024. PMID: 39603778 Review.
Genotype-Guided P2Y12 Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients: The CHAMP Trial - A Pilot Study and Safety Assessment.
Ingraham BS, Huxley SB, Lane CM, Gulati R, Lewis BR, Jaffe AS, Bell MR, Lerman A, Pereira NL, Moyer AM, Baudhuin LM, Rihal CS, Singh M. Ingraham BS, et al. Among authors: pereira nl. Mayo Clin Proc. 2024 Nov 26:S0025-6196(24)00307-0. doi: 10.1016/j.mayocp.2024.05.030. Online ahead of print. Mayo Clin Proc. 2024. PMID: 39601743
Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study.
Figueiral M, Paldino A, Wilke MVMB, Farris JD, Verheijen J, Giudicessi JR, Ackerman MJ, Olson JE, Arroyo J, Olson RJ, Klee EW, Pereira NL. Figueiral M, et al. Among authors: pereira nl. Mayo Clin Proc. 2024 Nov;99(11):1732-1743. doi: 10.1016/j.mayocp.2024.05.027. Epub 2024 Oct 10. Mayo Clin Proc. 2024. PMID: 39387793
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.
Huxley S, Moriarty J, Hlatky MA, Lennon R, Bailey K, Bell M, Geller N, Lerman A, Mathew V, Rosenberg Y, Farkouh M, Rihal C, Borah B, Pereira NL. Huxley S, et al. Among authors: pereira nl. Pharmacogenomics J. 2024 Oct 8;24(6):32. doi: 10.1038/s41397-024-00353-y. Pharmacogenomics J. 2024. PMID: 39379363 Clinical Trial.
195 results